These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34660731)

  • 21. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Rosenqvist M
    Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.
    Gao Y; Chang S; Du X; Dong J; Xu X; Zhou Y; Lip GYH; Ma C
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):579-587. PubMed ID: 31077081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
    Allen LA; Fonarow GC; Simon DN; Thomas LE; Marzec LN; Pokorney SD; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Chang P; Peterson ED; Piccini JP;
    J Am Coll Cardiol; 2015 Jun; 65(25):2691-8. PubMed ID: 26112191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin-associated mortality: a systematic review and meta-analysis of the literature.
    Vamos M; Erath JW; Hohnloser SH
    Eur Heart J; 2015 Jul; 36(28):1831-8. PubMed ID: 25939649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
    Chang SS; Gao Y; Xia SJ; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):728-734. PubMed ID: 32957754
    [No Abstract]   [Full Text] [Related]  

  • 27. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
    Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
    Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
    Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
    Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation.
    Kytö V; Saraste A; Rautava P; Tornio A
    Basic Clin Pharmacol Toxicol; 2022 Jun; 130(6):655-665. PubMed ID: 35420260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation.
    Zeng WT; Liu ZH; Li ZY; Zhang M; Cheng YJ
    Medicine (Baltimore); 2016 Mar; 95(12):e2949. PubMed ID: 27015169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
    Singh S; Moore H; Karasik PE; Lam PH; Wopperer S; Arundel C; Tummala L; Anker MS; Faselis C; Deedwania P; Morgan CJ; Zeng Q; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Dec; 133(12):1460-1470. PubMed ID: 32603789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Integrative Comparative Study Between Digoxin and Amiodarone as an Emergency Treatment for Patients With Atrial Fibrillation With Evidence of Heart Failure: A Systematic Review and Meta-Analysis.
    Zaki HA; Bashir K; Iftikhar H; Salem W; Mohamed EH; Elhag HM; Hendy M; Kassem AAO; Salem EE; Elmoheen A
    Cureus; 2022 Jul; 14(7):e26800. PubMed ID: 35971374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
    Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of beta-blockers on mortality in patients with heart failure and atrial fibrillation: A meta-analysis of observational cohort and randomized controlled studies.
    Ma GG; Fang Q; Wang FX
    Cardiol J; 2019; 26(6):744-752. PubMed ID: 30009373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure-Results from the DANISH trial.
    Boas R; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Dixen U
    Am Heart J; 2021 Feb; 232():61-70. PubMed ID: 33144085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.